Page last updated: 2024-09-02

kt 5823 and n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine

kt 5823 has been researched along with n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine in 1 studies

Compound Research Comparison

Studies
(kt 5823)
Trials
(kt 5823)
Recent Studies (post-2010)
(kt 5823)
Studies
(n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine)
Trials
(n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine)
Recent Studies (post-2010) (n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine)
3170594010167

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, Y; Tian, W; Xi, J; Xu, Z; Zhang, L1

Other Studies

1 other study(ies) available for kt 5823 and n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine

ArticleYear
Morphine prevents the mitochondrial permeability transition pore opening through NO/cGMP/PKG/Zn2+/GSK-3beta signal pathway in cardiomyocytes.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:2

    Topics: Analgesics, Opioid; Animals; Carbazoles; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Ethylenediamines; Fluorescent Dyes; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Animal; Morphine; Myocytes, Cardiac; Nitric Oxide; Rats; Rats, Wistar; Signal Transduction; Zinc

2010
chemdatabank.com